Patents by Inventor Simon Paul Fletcher

Simon Paul Fletcher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11578117
    Abstract: Provided herein are, inter alia, antibodies, antigen-binding antibody fragments, cells, polynucleotides, compositions, kits, and methods relating to the detection of HBV protein X (HBx), e.g., in vitro and in vivo. Included are antibodies and fragments thereof that bind HBx, as well as kits, cells, and compositions comprising such antibodies and fragments.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: February 14, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Simon Paul Fletcher, Christian Alfons Voitenleitner
  • Publication number: 20210122808
    Abstract: Provided herein are, inter alia, antibodies, antigen-binding antibody fragments, cells, polynucleotides, compositions, kits, and methods relating to the detection of HBV protein X (HBx), e.g., in vitro and in vivo. Included are antibodies and fragments thereof that bind HBx, as well as kits, cells, and compositions comprising such antibodies and fragments.
    Type: Application
    Filed: November 12, 2020
    Publication date: April 29, 2021
    Inventors: Simon Paul Fletcher, Christian Alfons Voitenleitner
  • Patent number: 10870691
    Abstract: Provided herein are, inter alia, antibodies, antigen-binding antibody fragments, cells, polynucleotides, compositions, kits, and methods relating to the detection of HBV protein X (HBx), e.g., in vitro and in vivo. Included are antibodies and fragments thereof that bind HBx, as well as kits, cells, and compositions comprising such antibodies and fragments.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: December 22, 2020
    Assignee: GILEAD SCIENCES, INC.
    Inventors: Simon Paul Fletcher, Christian Alfons Voitenleitner
  • Publication number: 20190309052
    Abstract: Provided herein are, inter alia, antibodies, antigen-binding antibody fragments, cells, polynucleotides, compositions, kits, and methods relating to the detection of HBV protein X (HBx), e.g., in vitro and in vivo. Included are antibodies and fragments thereof that bind HBx, as well as kits, cells, and compositions comprising such antibodies and fragments.
    Type: Application
    Filed: April 1, 2019
    Publication date: October 10, 2019
    Applicant: Gilead Sciences, Inc.
    Inventors: Simon Paul Fletcher, Christian Alfons Voitenleitner